Nicotine effects on affective response in depression-prone smokers

Spring, Bonnie; Cook, Jessica W.; Appelhans, Bradley M.; Maloney, Anne Marie; Richmond, Malia; Vaughn, Jocelyn; VanderVeen, Joseph W.; Hedeker, Donald

doi:10.1007/s00213-007-0977-7

Cited by 58 publications

(61 citation statements)

References 74 publications

(56 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Segundo Ismail, Sloggett e Stavola (2000), indivíduos deprimidos têm baixa autoestima, são pessimistas e tornam-se negligentes relativamente à sua saúde, adotando comportamentos de risco, como fumar. Segundo Spring et al (2008), em fumadores deprimidos, o comportamento tabágico agrava o afeto negativo. Outros fumadores relatam que usam o tabaco como meio para reduzir a ansiedade para atenuar as anomalias afetivas e neurobiológicas associadas ao seu problema psicológico (Feldner et al, 2009).…”

Section: Discussionunclassified

Preditores da qualidade de vida em fumadores e abstinentes

Andrade

Pereira

2012

Temas Psicol.

View full text Add to dashboard Cite

ResumoEste estudo teve como objetivo avaliar qualidade de vida, morbilidade psicológica, dependência nicotínica e coping familiar em fumadores e abstinentes. 116 Life quality predictors in smokers and abstinents AbstractThis study aimed to evaluate quality of life, psychological morbidity, nicotine dependence and family coping in smokers and abstinents. 116 smokers and 117 abstinents, from both sexes, participated in the study. All participants answered the following instruments: Socio-Demographic; Medical Outcomes Study Short Form 36 (MOS SF-36); Depresion, Anxiety, Stress Scales (DASS); Fagerström Test for Nicotine Dependence (FTND) and Family Crises-Oriented Personal Evaluation Scales (F-COPES). According to the results, in smokers who also have a partner who smokes, high nicotine dependence and psychological morbidity predict less physical quality of life. High psychological morbidity and passive assessment, predict less quality of life. As for abstinents, having chronic respiratory disease, high psychological morbidity and looking for spiritual support predicted poorer quality of physical life. Being female, having chronic respiratory disease and psychological morbidity predicted lower mental quality of life. Hereafter, intervention programs should include partners as well as psychological morbidity and coping strategies in order to increase quality of life.

show abstract

Section: Discussionunclassified

Preditores da qualidade de vida em fumadores e abstinentes

Andrade

Pereira

2012

Temas Psicol.

View full text Add to dashboard Cite

show abstract

“…45 In a second study, among smokers with current or past depression, RNC cigarettes were less effective than NNC cigarettes at increasing positive mood and reducing negative mood during positive mood induction, but NNC cigarettes also exacerbated the effects of negative mood induction on negative mood. 46 Another study found that smokers with a history of depression smoked more NNC and RNC cigarette puffs during either neutral or negative mood induction, suggesting that they experience stronger acute reinforcing effects of smoking in general, regardless of nicotine content or mood. 47 To our knowledge, the current study is the first to examine the effects of an extended period of RNC cigarette use among people with elevated depressive symptoms, and the first to assess multiple behavioral, subjective, and physiological measures relevant to estimating the potential effects of a nicotine reduction policy in these smokers.…”

Section: Discussionmentioning

confidence: 99%

Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms

Tidey

Pacek

Koopmeiners

et al. 2016

NICTOB

View full text Add to dashboard Cite

Background: The FDA recently acquired regulatory authority over tobacco products, leading to renewed interest in whether reducing the nicotine content of cigarettes would reduce tobacco dependence in the United States. Given the association between depressive symptoms and cigarette smoking, it is important to consider whether smokers with elevated depressive symptoms experience unique benefits or negative consequences of nicotine reduction. Methods: In this secondary analysis of a randomized clinical trial that examined the effects of cigarettes varying in nicotine content over a 6-week period in non-treatment-seeking smokers, we used linear regression to examine whether baseline depressive symptom severity (scores on the Center for Epidemiologic Studies Depression Scale [CES-D]) moderated the effects of reduced-nicotine content (RNC) cigarettes, relative to normal-nicotine content (NNC) cigarettes, on smoking rates, depressive symptom severity, and related subjective and physiological measures. Results: Of the 717 participants included in this analysis, 109 (15.2%) had CES-D scores ≥ 16, indicative of possible clinical depression. Relative to NNC cigarettes, RNC cigarettes reduced smoking rates, nicotine dependence, and cigarette craving, and these effects were not significantly moderated by baseline CES-D score. A significant interaction between baseline CES-D score and cigarette condition on week 6 CES-D score was observed (p < .05); among those with CES-D scores ≥ 16 at baseline, those assigned to RNC cigarettes had lower week 6 CES-D scores than those assigned to NNC cigarettes. Among those in the lowest nicotine content conditions, biochemically confirmed

show abstract

“…The relationship between changes in positive affect and risk for smoking lapse has received far less attention than negative affective processes. Although mechanisms for the functional role of nicotine and a nicotine withdrawal -related shift in the experience of rewards have been hypothesized ( Cook et al, 2004 ;Spring et al, 2008 ), further research is needed to understand factors that may infl uence changes in positive affect clinically. Changes in positive affect prior to attempts at cessation may present a new target for improving treatment outcomes.…”

Section: Discussionmentioning

confidence: 99%

Section: Original Investigationmentioning

confidence: 99%

“…Increases in negative affect ( Brown et al, 2001 ;Hall et al, 1996 ;Spring et al, 2008 ) and decreases in positive affect ( al ' Absi et al, 2004 ;Spring et al, 2008 ) during cessation have been proposed as mechanisms for relapse that may be concentrated among depression-prone smokers. For example, depression-prone smokers are more likely to report smoking when experiencing negative affect ( Brandon, 1994 ) and have demonstrated an enhanced response to positive affect situations when selfadministering nicotine ( Spring et al, 2008 ). Further, smokers who reported higher levels of depression proneness by selfreport ( Zelman et al, 1992 ) or by evidence of a history of recurrent depression ( Brown et al, 2001 ) and smokers who report a day-to-day pattern of smoking when emotionally upset have been shown to be at heightened risk for relapse after cessation ( Shiffman et al, 2007 ;Zelman et al).…”

Section: Original Investigationmentioning

confidence: 99%

See 1 more Smart Citation

Impact of bupropion and cognitive–behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment

Strong¹,

Kahler²,

Leventhal³

et al. 2009

Nicotine &Amp; Tobacco Research

View full text Add to dashboard Cite

affect and suggest the need to better understand the role of low positive affect as a risk factor for early lapse. IntroductionRelapse to smoking is a common problem in cessation treatment. Research on the processes underlying smoking relapse has often focused on the role of affective disturbance and nicotine withdrawal symptoms that occur during a quit attempt ( Piasecki, 2006 ). The motives underpinning relapse risk are dynamic and vary in accordance with affective fl uctuations over the course of a cessation attempt ( Piasecki, Jorenby, Smith, Fiore, & Baker, 2003a, 2003bShiffman et al., 2007 ). Given the strong link between fl uctuations in affect and relapse to smoking ( Kenford et al., 2002 ;Shiffman et al., 2007 ), affect processes have been implicated as a primary motivational basis for contributing to urges to smoke, maintaining smoking behavior, and derailing cessation attempts.Signifi cant affective changes occur during smoking cessation. For the average smoker, mood disturbance increases on quitting and then decreases gradually over the next several weeks ( Piasecki et al., 2003a ). However, signifi cant interindividual variability exists in affective trajectories, suggesting that many smokers do not follow this typical pattern ( Burgess et al., 2002 ;Kahler et al., 2002 ;McCarthy, Piasecki, Fiore, & Baker, 2006 ;Piasecki & Baker, 2000 ;Piasecki, Fiore, & Baker, 1998 ;Piasecki, Jorenby, Smith, Fiore, & Baker, 2003c ). Observed variability AbstractIntroduction : Bupropion and cognitive -behavioral treatment (CBT) for depression have been used as components of treatments designed to alleviate affective disturbance during smoking cessation. Studies of treatment-related changes in precessation affect or urges to smoke are needed to evaluate the proposed mechanisms of these treatments. Methods :The present report examines affective trajectories and urges to smoke prior to, on quit day, and after quitting in a sample of 524 smokers randomized to receive bupropion versus placebo and CBT versus standard smoking cessation CBT.

show abstract

Nicotine effects on affective response in depression-prone smokers

Abstract: Self-administering nicotine appears to improve depression-prone smokers' emotional response to a pleasant stimulus.

Cited by 58 publications

References 74 publications

Preditores da qualidade de vida em fumadores e abstinentes

Preditores da qualidade de vida em fumadores e abstinentes

Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms

Impact of bupropion and cognitive–behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment

Contact Info

Product

Resources

About